October 10, 2019
Heidelberg Pharma doubles revenue, net loss falls to €5.6, in first nine months
Heidelberg Pharma reported that its net loss for the first nine months of the fiscal year fell to €5.6 million from previous year’s €7.4 million, referring the result to the sales revenue and income totaling €6.7 million, from €3.5 million in the same period last year.